Queensland Lung Cancer Screening Study: Rationale, design and methods

Internal Medicine Journal

Volumn 43, Issue 2, 2013, Pages 174-182

  Marshall, H M ^a,b   Bowman, R V ^a,b   Crossin, J ^a   Lau, M A ^a   Slaughter, R E ^a   Passmore, L H ^a   Mccaul, E M ^a   Courtney, D A ^a   Windsor, M N ^a   Yang, I A ^a,b   Smith, I R ^c   Keir, B J ^d   Hayes, T J ^a   Redmond, S J ^a   Zimmerman, P V ^a   Fong, K M ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ST ANDREW S WAR MEMORIAL HOSPITAL   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Lung neoplasms radiography; Mass screening; Radiography; Thoracic; Tomography; X ray computed* adverse effect; X ray computed* method

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL ASSESSMENT; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SMOKING CESSATION;

AGED; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUEENSLAND; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873742902     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02789.x     Document Type: Article

References (41)

1. Australian Institute of Health and Welfare. Chronic Diseases and Associated Risk Factors in Australia. Cat No. PHE 81 Canberra: AIHW; 2006.
2. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: An Overview. Cancer series no. 46. Cat. no. CAN 42.Canberra: AIHW; 2008.
3. Australian Institute of Health and Welfare. ACIM (Australian Cancer Incidence and Mortality) Books. Canberra: AIHW; 2010.
4. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES etal. Clinical features of 5, 628 primary lung cancer patients. Chest 2005; 128: 452-462.
5. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: First Results. Canberra: AIHW; 2008.
6. Manser R, Irving L, Stone C, Byrnes G, Abramson M, Campbell D. Screening for Lung Cancer (Cochrane Review). Chichester: The Cochrane Library, John Wiley & Sons Ltd; 2004.
7. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR etal. Screening by chest radiograph and lung cancer mortality. JAMA 2011; 306: 1865-1873.
8. Yau G, Lock M, Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer 2007; 58: 161-170.
9. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007; 132: 193-199.
10. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
11. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R etal. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229.
12. Australian Radiation Protection and Nuclear Safety Agency. Code of Practice for the Exposure of Humans to Ionizing Radiation for Research Purposes. In: Radiation Protection Series No. 8; 2005.
13. Brenner D. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231: 440-445.
14. Cagnon CH, Cody DD, McNitt-Gray MF, Seibert JA, Judy PF, Aberle DR. Description and implementation of a quality control program in an imaging-based clinical trial. Acad Radiol 2006; 13: 1431-1441.
15. National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011; 258: 243-253.
16. Mettler FA, Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248: 254-263.
17. Webb D, Solomon S, Thompson J. Background radiation levels and medical exposure levels in Australia. Radiat Prot Australas 1999; 16: 25-32.
18. Armato SG, Roberts RY, Kocherginsky M, Aberle DR, Kazerooni EA, MacMahon H etal. Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of 'truth'. Acad Radiol 2009; 16: 28-38.
19. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET etal. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 2009; 250: 264-272.
20. Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Libby DM etal. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004; 231: 164-168.
21. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP etal. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237: 395-400.
22. Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005; 48: 171-185.
23. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151: 716-726.
24. The Canadian Task Force on Preventive Health C. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. Can Med Assoc J 2011; 183: 1991-2001.
25. Bewley S. The NHS breast screening programme needs independent review. BMJ 2011; 343: d6894.
26. Richards M. An independent review is under way. BMJ 2011; 343: d6843.
27. Nakayama T, Kusunoki Y, Suzuki T. Quality control in lung cancer screening in Japan. Jpn J Lung Cancer 2005; 45: 183-187.
28. IASLC Task Force on CT Screening. Position Statement. 2011 [cited 2011 Dec 1]. Available from URL: http://iaslc.org/policies/statement-on-ct-screening/
29. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D etal. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon: International Agency for Research on Cancer; 2010.
30. Shack L, Jordan C, Thomson CS, Mak V, Moller H. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 2008; 8: 271.
31. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008; 19: 1383-1390.
32. Australian Institute of Health and Welfare. BreastScreen Australia Monitoring Report 2006-2007 and 2007-2008. Cancer series no. 55. Cat. no. CAN 51. Canberra: AIHW; 2010.
33. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y etal. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351: 1242-1245.
34. Wormanns D, Ludwig K, Beyer F, Heindel W, Diederich S. Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol 2005; 15: 14-22.
35. Revel M-P, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 2004; 231: 453-458.
36. Revel M-P, Lefort C, Bissery A etal. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology 2004; 231: 459-466.
37. Takahashi M, Maguire WM, Ashtari M, Khan A, Papp Z, Alberico R etal. Low-dose spiral computed tomography of the thorax: comparison with the standard-dose technique. Invest Radiol 1998; 33: 68-73.
38. Mayo JR, Hartman TE, Lee KS, Primack SL, Vedal S, Muller NL. CT of the chest: minimal tube current required for good image quality with the least radiation dose. AJR Am J Roentgenol 1995; 164: 603-607.
39. Diederich S, Lenzen H, Windmann R, Puskas Z, Yelbuz TM, Henneken S etal. Pulmonary nodules: experimental and clinical studies at low-dose CT. Radiology 1999; 213: 289-298.
40. Hein PA, Romano VC, Rogalla P, Klessen C, Lembcke A, Dicken V etal. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Rofo 2009; 181: 24-31.
41. Silverman JD, Paul NS, Siewerdsen JH. Investigation of lung nodule detectability in low-dose 320-slice computed tomography. Med Phys 2009; 36: 1700-1710.